Nomura Holdings’s Celldex Therapeutics CLDX Stock Holding History

Nomura Holdings’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$305K	Buy	+8,201	New	+$265K	﹤0.01%	1603
2014 Q3	–	Sell	-3,427	Closed	-$834K	–	2793
2014 Q2	$834K	Buy	+3,427	New	+$774K	﹤0.01%	1521
2014 Q1	–	Sell	-1,721	Closed	-$625K	–	2741
2013 Q4	$625K	Sell	1,721 -284	-14%	-$109K	﹤0.01%	1183
2013 Q3	$1.06M	Sell	2,005 -60	-3%	-$20.6K	0.01%	1055
2013 Q2	$482K	Buy	+2,065	New	+$407K	﹤0.01%	1347

Other funds holding CLDX

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Holdings's CLDX Position: Q2 2026 in Review

Nomura Holdings opened a new position in Celldex Therapeutics (CLDX) in Q2 2026: 8,201 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #1603 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in CLDX as recently as Q2 2014.

Nomura Holdings first reported a position in CLDX in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.06M in Q3 2013. 253 funds tracked by Wall St. Rank hold CLDX as of Q2 2026.

Nomura Holdings held 8,201 shares of Celldex Therapeutics worth $305K as of Q2 2026.
Celldex Therapeutics was a new Nomura Holdings position in Q2 2026.
Celldex Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1603 holding.
Nomura Holdings first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 5 quarters since.
Nomura Holdings's Celldex Therapeutics position peaked at $1.06M in Q3 2013.
253 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.